Home LiteratureArticle Details
PMID: 11792833 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.

Evaluation of linkage of breast cancer to the putative BRCA3 locus on chromosome 13q21 in 128 multiple case families from the Breast Cancer Linkage Consortium.

Thompson D, Szabo CI, Mangion J, Oldenburg RA, Odefrey F, Seal S, Barfoot R, Kroeze-Jansema K, Teare D, Rahman N, Renard H, Mann G, Hopper JL, Buys SS, Andrulis IL, Senie R, Daly MB, West D, Ostrander EA, Offit K, Peretz T, Osorio A, Benitez J, Nathanson KL, Sinilnikova OM, Olàh E, Bignon YJ, Ruiz P, Badzioch MD, Vasen HF, Futreal AP, Phelan CM, Narod SA, Lynch HT, Ponder BA, Eeles RA, Meijers-Heijboer H, Stoppa-Lyonnet D, Couch FJ, Eccles DM, Evans DG, Chang-Claude J, Lenoir G, Weber BL, Devilee P, Easton DF, Goldgar DE, Stratton MR, KConFab Consortium

Abstract

The known susceptibility genes for breast cancer, including BRCA1 and BRCA2, only account for a minority of the familial aggregation of the disease. A recent study of 77 multiple case breast cancer families from Scandinavia found evidence of linkage between the disease and polymorphic markers on chromosome 13q21. We have evaluated the contribution of this candidate "BRCA3" locus to breast cancer susceptibility in 128 high-risk breast cancer families of Western European ancestry with no identified BRCA1 or BRCA2 mutations. No evidence of linkage was found. The estimated proportion (alpha) of families linked to a susceptibility locus at D13S1308, the location estimated by Kainu et al. [(2000) Proc. Natl. Acad. Sci. USA 97, 9603-9608], was 0 (upper 95% confidence limit 0.13). Adjustment for possible bias due to selection of families on the basis of linkage evidence at BRCA2 did not materially alter this result (alpha = 0, upper 95% confidence limit 0.18). The proportion of linked families reported by Kainu et al. (0.65) is excluded with a high degree of confidence in our dataset [heterogeneity logarithm of odds (HLOD) at alpha = 0.65 was -11.0]. We conclude that, if a susceptibility gene does exist at this locus, it can only account for a small proportion of non-BRCA1/2 families with multiple cases of early-onset breast cancer.

MeSH Terms
Australia Breast Neoplasms/genetics Chromosomes, Human, Pair 13/genetics Europe Female Genes, Tumor Suppressor Genetic Linkage Humans Lod Score North America
Authors & Affiliations
49 authors, click to expand affiliations / ORCID
Thompson Deborah
CRC Genetic Epidemiology Unit, Strangeways Research Laboratories, University of Cambridge, Cambridge CB1 4RN, United Kingdom.
Szabo Csilla I
Mangion Jon
Oldenburg Rogier A
Odefrey Fabrice
Seal Sheila
Barfoot Rita
Kroeze-Jansema Karin
Teare Dawn
Rahman Nazneen
Renard Hélène
Mann Graham
Hopper John L
Buys Saundra S
Andrulis Irene L
Senie Ruby
Daly Mary B
West Dee
Ostrander Elaine A
Offit Ken
Peretz Tamar
Osorio Ana
Benitez J
Nathanson Katherine L
Sinilnikova Olga M
Olàh Edith
Bignon Yves-Jean
Ruiz Pablo
Badzioch Michael D
Vasen Hans F A
Futreal Andrew P
Phelan Catherine M
Narod Steven A
Lynch Henry T
Ponder Bruce A J
Eeles Ros A
Meijers-Heijboer Hanne
Stoppa-Lyonnet Dominique
Couch Fergus J
Eccles Diana M
Evans D Gareth
Chang-Claude Jenny
Lenoir Gilbert
Weber Barbara L
Devilee Peter
Easton Douglas F
Goldgar David E
Stratton Michael R
KConFab Consortium
References (18)
18 references, click to expand
  1. Somatic deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locus.
    Proc Natl Acad Sci U S A. 2000 Aug 15;97(17):9603-8 PMID: 10944226
  2. Linkage analysis of 56 multiplex families excludes the Cowden disease gene PTEN as a major contributor to familial breast cancer.
    J Med Genet. 1999 Sep;36(9):720-1 PMID: 10507734
  3. Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Anglian Breast Cancer Study Group.
    Br J Cancer. 2000 Nov;83(10):1301-8 PMID: 11044354
  4. Interpreting epidemiological research: blinded comparison of methods used to estimate the prevalence of inherited mutations in BRCA1.
    J Med Genet. 2001 Dec;38(12):824-33 PMID: 11748305
  5. Genetic analysis of breast cancer in the cancer and steroid hormone study.
    Am J Hum Genet. 1991 Feb;48(2):232-42 PMID: 1990835
  6. Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium.
    Am J Hum Genet. 1993 Apr;52(4):678-701 PMID: 8460634
  7. Faster sequential genetic linkage computations.
    Am J Hum Genet. 1993 Jul;53(1):252-63 PMID: 8317490
  8. Loss of heterozygosity and linkage analysis in breast carcinoma: indication for a putative third susceptibility gene on the short arm of chromosome 8.
    Oncogene. 1995 Mar 2;10(5):1023-6 PMID: 7898921
  9. The VITESSE algorithm for rapid exact multilocus linkage analysis via genotype set-recoding and fuzzy inheritance.
    Nat Genet. 1995 Dec;11(4):402-8 PMID: 7493020
  10. Parametric and nonparametric linkage analysis: a unified multipoint approach.
    Am J Hum Genet. 1996 Jun;58(6):1347-63 PMID: 8651312
  11. A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes.
    Nat Genet. 1996 May;13(1):117-9 PMID: 8673089
  12. Strong indication for a breast cancer susceptibility gene on chromosome 8p12-p22: linkage analysis in German breast cancer families.
    Oncogene. 1997 Feb 13;14(6):741-3 PMID: 9038382
  13. Mutations in BRCA1 and BRCA2 in breast cancer families: are there more breast cancer-susceptibility genes?
    Am J Hum Genet. 1997 Mar;60(3):486-95 PMID: 9042907
  14. Population genetics of BRCA1 and BRCA2.
    Am J Hum Genet. 1997 May;60(5):1013-20 PMID: 9150148
  15. True and false positive peaks in genomewide scans: applications of length-biased sampling to linkage mapping.
    Am J Hum Genet. 1997 Aug;61(2):430-8 PMID: 9311749
  16. Mutation sharing, predominant involvement of the MLH1 gene and description of four novel mutations in hereditary nonpolyposis colorectal cancer. Mutations in brief no. 144. Online.
    Hum Mutat. 1998;11(6):482 PMID: 10200055
  17. Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer.
    J Natl Cancer Inst. 1999 Jun 2;91(11):943-9 PMID: 10359546
  18. Absence of evidence for a familial breast cancer susceptibility gene at chromosome 8p12-p22.
    Oncogene. 2000 Aug 24;19(36):4170-3 PMID: 10962578
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
2002-01-22
Epub
2002-00-15
Pages
827-31
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC117390
Subset
IM
Grants
NCI NIH HHS · U01 CA069417 · United States
NCI NIH HHS · U01 CA069638 · United States
NCI NIH HHS · CA69631 · United States
NCI NIH HHS · U01 CA069467 · United States
NCI NIH HHS · CA69467 · United States
NCI NIH HHS · U01 CA069398 · United States
NCI NIH HHS · CA69417 · United States
NCI NIH HHS · U01 CA069631 · United States
NCI NIH HHS · CA69638 · United States
NCI NIH HHS · CA69398 · United States
NCI NIH HHS · U01 CA069446 · United States
NCI NIH HHS · CA69446 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]